Check out our most popular compounded medications! Get Started
The Itraconazole 2%/Tobramycin 5%/Vancomycin 5% Topical Ointment is a specialized semi-solid formulation designed for external application to the skin. This ointment is dispensed in a tube and provides a greasy or oily base, which facilitates the localized delivery of its active ingredients.
This ointment is primarily used for the treatment of complex skin infections where fungal and bacterial pathogens coexist. It is suitable for managing conditions such as infected dermatitis, cutaneous abscesses, and wound infections, where the presence of both bacteria and fungi is confirmed or suspected. The ointment's base also aids in protecting the affected area, providing an optimal environment for healing.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Our Itraconazole 2%/Tobramycin 5%/Vancomycin 5% Topical Ointment is a specialized semi-solid formulation that is meticulously prepared to ensure the highest quality and efficacy for treating localized skin conditions. This ointment is dispensed in a tube for convenient external application to the skin. The base of the ointment is designed to be greasy or oily, which not only facilitates the delivery of the active ingredients to the affected area but also provides a protective barrier that can aid in the healing process.
The combination of Itraconazole, Tobramycin, and Vancomycin in this ointment offers a broad spectrum of antimicrobial activity. Itraconazole is an antifungal agent that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes, thereby exerting its effect against a wide range of fungal infections. Vancomycin, a glycopeptide antibiotic, is included for its potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It inhibits cell wall synthesis in bacteria, which is critical for their survival.
This triple-action ointment is particularly useful in treating skin infections where mixed microbial flora is present or suspected. It can be used for conditions such as infected dermatitis, wound infections, and other skin inflammations where bacterial and fungal pathogens are contributing to the disease state. The ointment's formulation is designed to target the site of infection directly, providing high local concentrations of the active drugs while minimizing systemic absorption and potential side effects.
For patients, it is important to apply the ointment as directed by a healthcare professional, usually to the affected area(s) of the skin. The area should be clean and dry before application. For prescribers, this formulation offers a potent combination therapy that can be used to manage complex skin infections with a single topical treatment, potentially improving patient compliance and outcomes.
As with any medication, it is crucial to be aware of potential side effects and contraindications. Patients should be monitored for signs of local irritation or hypersensitivity reactions, and prescribers should consider the patient's overall medication profile to avoid drug interactions. It is also important to use this ointment judiciously to prevent the development of antibiotic resistance.
If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of our compounded medications.
The combination of Itraconazole, Tobramycin, and Vancomycin in a topical ointment is a unique formulation designed to treat localized skin infections, particularly those which are resistant to standard treatments. Itraconazole is an antifungal agent that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Tobramycin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis, and Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis in bacteria. Together, these agents provide broad-spectrum coverage against a variety of fungal and bacterial pathogens.
When using this topical ointment, it is important to consider potential drug interactions. Itraconazole can interact with a wide range of medications due to its inhibition of the cytochrome P450 enzyme system, particularly CYP3A4. This can lead to increased levels of drugs metabolized by this pathway, potentially causing toxicity. Examples include certain statins, calcium channel blockers, and immunosuppressants. However, since the systemic absorption of itraconazole from a topical formulation is likely to be minimal, the risk of systemic interactions is reduced.
Tobramycin, when used topically, has a low risk of systemic absorption and therefore a low risk of systemic drug interactions. However, caution should be exercised when it is used in conjunction with other nephrotoxic or ototoxic drugs, as systemic absorption, though minimal, could still contribute to cumulative toxicity, especially in patients with impaired renal function or in those applying the ointment over large surface areas or broken skin.
Vancomycin, similarly, has minimal systemic absorption when applied topically, but caution is advised if used with other drugs known to affect renal function or hearing. Systemic vancomycin interacts with anesthetic agents, nondepolarizing muscle relaxants, and other nephrotoxic drugs, but these interactions are unlikely to be relevant with topical administration unless applied to large surface areas or to open wounds where systemic absorption may be more significant.
It is also important to consider the potential for additive local skin reactions or irritation when using this combination ointment, especially if the patient has a history of sensitivity to topical preparations. Patients should be monitored for signs of local adverse effects such as redness, itching, or contact dermatitis. If such reactions occur, discontinuation of the ointment and consultation with a healthcare provider is recommended.
Given the complexity of this formulation, prescribers should review the patient's current medication list for potential interactions and adjust therapy accordingly. Patients should be advised to inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements. If you have any questions or require further information regarding this formulation and its potential drug interactions, please reach out to us at Bayview Pharmacy for assistance.
The Itraconazole 2%/Tobramycin 5%/Vancomycin 5% Topical Ointment is a specialized medication compounded to treat various skin conditions, particularly those involving fungal and bacterial infections. This semi-solid formulation is designed to be applied externally to the skin, where it provides a greasy or oily base that not only facilitates the delivery of the active ingredients directly to the affected area but also creates a protective barrier that can help maintain hydration and support the healing process.
Itraconazole is an antifungal agent that works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. By disrupting the cell membrane's integrity, itraconazole effectively causes fungal cells to become leaky and ultimately leads to their death. This makes it particularly useful in treating skin infections caused by a variety of fungi, including dermatophytes and yeasts.
Tobramycin is an aminoglycoside antibiotic that exerts its bactericidal effects by binding to the bacterial ribosome, thereby inhibiting protein synthesis. This action causes the bacteria to be unable to grow and replicate, leading to their elimination.
Vancomycin works by inhibiting cell wall synthesis in bacteria, which is essential for their survival and replication. By disrupting this process, vancomycin leads to bacterial cell death.
The combination of these three agents in one topical ointment allows for a broad-spectrum approach to treating skin infections. The ointment is particularly useful for treating mixed infections where both fungal and bacterial pathogens are present, or when the precise causative agent has not been identified. By delivering the medication directly to the site of infection, the ointment minimizes systemic absorption and reduces the potential for side effects that can occur with oral or intravenous administration of these drugs.
Patients and prescribers should note that this formulation is intended for localized treatment and should be applied as directed by a healthcare professional. The ointment should be used with caution in patients with known sensitivities to any of its components. As with all medications, it is important to use this ointment only for the condition for which it was prescribed and to follow the recommended dosage and application instructions closely.
If you have any questions about this formulation or its appropriate use, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
This compounded ointment is designed for the treatment of various skin conditions that may involve inflammation, bacterial, and fungal infections, as well as aiding in the healing process of wounds. The specific combination of Itraconazole, Tobramycin, and Vancomycin in the formulation targets both fungal and bacterial pathogens.
To apply the ointment, clean and dry the affected area first. Then, apply a thin layer of the ointment to the area as directed by your healthcare provider, usually twice daily or as prescribed. Do not cover the treated area with bandages or other coverings unless instructed to do so by your doctor.
The ointment may be used on wounds as directed by a healthcare professional. However, it should not be used on large, deep, or puncture wounds without proper medical advice due to the varying nature of wounds and the risk of systemic absorption.
Possible side effects can include local irritation, itching, or redness at the site of application. More serious side effects may occur but are less common. If you experience severe burning, stinging, or other discomfort, discontinue use and consult with your healthcare provider.
Pregnant or breastfeeding women should only use this ointment if it is clearly needed and recommended by a healthcare provider, as there is potential for absorption and risk to the fetus or infant.
The safety and effectiveness of this ointment in children have not been fully established. Use in children should be under the guidance and supervision of a pediatrician or healthcare provider.
Store the ointment at room temperature away from light and moisture. Do not freeze it. Keep the tube tightly closed when not in use. Dispose of any unused ointment after the expiration date or as instructed by your pharmacist.
If you miss a dose, apply the ointment as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Before using other topical preparations, consult with your healthcare provider as there may be interactions or increased risk of side effects with concurrent use.
Avoid contact with the eyes, nose, mouth, and other mucous membranes. Wash your hands before and after applying the ointment unless you are treating an area on the hands. If the medication gets in these areas, rinse thoroughly with water. Additionally, inform your healthcare provider of your full medical history and of all the products you use before starting this treatment.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
